| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 151 | 2023 | 12220 | 4.910 |
Why?
|
| Genetic Predisposition to Disease | 123 | 2023 | 17400 | 3.500 |
Why?
|
| Multifactorial Inheritance | 39 | 2023 | 1190 | 3.310 |
Why?
|
| Polymorphism, Single Nucleotide | 120 | 2023 | 15494 | 2.960 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 45 | 2023 | 3649 | 2.810 |
Why?
|
| Linkage Disequilibrium | 33 | 2023 | 1995 | 2.700 |
Why?
|
| Genetic Variation | 55 | 2023 | 6540 | 2.610 |
Why?
|
| Models, Genetic | 31 | 2023 | 3493 | 2.050 |
Why?
|
| Schizophrenia | 43 | 2023 | 6874 | 2.030 |
Why?
|
| Genome, Human | 39 | 2023 | 4420 | 1.460 |
Why?
|
| Genetics, Population | 19 | 2023 | 933 | 1.420 |
Why?
|
| DNA Copy Number Variations | 16 | 2023 | 1940 | 1.270 |
Why?
|
| Genetic Loci | 16 | 2023 | 2572 | 1.260 |
Why?
|
| Tourette Syndrome | 10 | 2021 | 379 | 1.210 |
Why?
|
| Quantitative Trait Loci | 23 | 2021 | 2015 | 1.180 |
Why?
|
| Child Development Disorders, Pervasive | 10 | 2017 | 615 | 1.160 |
Why?
|
| Gene Frequency | 30 | 2023 | 3587 | 1.140 |
Why?
|
| Phenotype | 51 | 2023 | 16331 | 1.120 |
Why?
|
| Twins | 5 | 2020 | 339 | 1.080 |
Why?
|
| Genetics, Behavioral | 3 | 2020 | 53 | 1.080 |
Why?
|
| Software | 16 | 2023 | 4434 | 1.040 |
Why?
|
| Biological Specimen Banks | 6 | 2023 | 707 | 0.990 |
Why?
|
| Genetic Association Studies | 12 | 2023 | 2699 | 0.910 |
Why?
|
| Disease | 6 | 2020 | 681 | 0.870 |
Why?
|
| Bipolar Disorder | 15 | 2023 | 5024 | 0.870 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2021 | 544 | 0.860 |
Why?
|
| Mutation | 24 | 2023 | 29717 | 0.850 |
Why?
|
| Twin Studies as Topic | 4 | 2020 | 105 | 0.840 |
Why?
|
| Genotype | 51 | 2023 | 12946 | 0.790 |
Why?
|
| Haplotypes | 18 | 2023 | 2781 | 0.780 |
Why?
|
| Case-Control Studies | 54 | 2022 | 21719 | 0.750 |
Why?
|
| Genes, Dominant | 1 | 2023 | 880 | 0.730 |
Why?
|
| Data Interpretation, Statistical | 7 | 2018 | 2714 | 0.670 |
Why?
|
| Alleles | 28 | 2023 | 6931 | 0.670 |
Why?
|
| Sample Size | 9 | 2021 | 844 | 0.610 |
Why?
|
| Open Reading Frames | 2 | 2018 | 810 | 0.600 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2017 | 587 | 0.590 |
Why?
|
| Humans | 268 | 2023 | 742088 | 0.590 |
Why?
|
| Mental Disorders | 14 | 2019 | 6587 | 0.560 |
Why?
|
| Genetic Heterogeneity | 3 | 2017 | 732 | 0.560 |
Why?
|
| Genetic Markers | 18 | 2020 | 2633 | 0.540 |
Why?
|
| Heat-Shock Proteins | 1 | 2019 | 822 | 0.530 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 211 | 0.520 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 742 | 0.510 |
Why?
|
| Chromosome Mapping | 9 | 2015 | 4742 | 0.480 |
Why?
|
| Sex Characteristics | 5 | 2021 | 2585 | 0.460 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2019 | 1421 | 0.450 |
Why?
|
| Autistic Disorder | 5 | 2023 | 1174 | 0.450 |
Why?
|
| Macular Degeneration | 5 | 2010 | 980 | 0.410 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 238 | 0.400 |
Why?
|
| Homozygote | 10 | 2023 | 1777 | 0.390 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2023 | 3585 | 0.390 |
Why?
|
| Databases, Genetic | 8 | 2023 | 1780 | 0.390 |
Why?
|
| Obsessive-Compulsive Disorder | 7 | 2021 | 1442 | 0.380 |
Why?
|
| Computer Simulation | 16 | 2020 | 6191 | 0.380 |
Why?
|
| Meta-Analysis as Topic | 9 | 2019 | 1342 | 0.370 |
Why?
|
| Siblings | 6 | 2018 | 854 | 0.360 |
Why?
|
| Algorithms | 21 | 2023 | 13853 | 0.360 |
Why?
|
| Models, Statistical | 6 | 2016 | 5100 | 0.360 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 12071 | 0.360 |
Why?
|
| Neurotic Disorders | 3 | 2008 | 79 | 0.350 |
Why?
|
| Sequence Analysis, DNA | 13 | 2023 | 4801 | 0.350 |
Why?
|
| Pedigree | 11 | 2021 | 4646 | 0.350 |
Why?
|
| Genomics | 11 | 2023 | 5692 | 0.340 |
Why?
|
| Male | 107 | 2021 | 349538 | 0.340 |
Why?
|
| Female | 112 | 2021 | 379592 | 0.340 |
Why?
|
| Genome | 5 | 2020 | 1803 | 0.330 |
Why?
|
| DiGeorge Syndrome | 2 | 2022 | 177 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 7 | 2017 | 4465 | 0.320 |
Why?
|
| Genetic Linkage | 9 | 2016 | 2422 | 0.320 |
Why?
|
| Lipase | 1 | 2010 | 315 | 0.310 |
Why?
|
| Genetic Pleiotropy | 2 | 2019 | 182 | 0.300 |
Why?
|
| Exons | 2 | 2018 | 2431 | 0.300 |
Why?
|
| Lipids | 5 | 2021 | 3302 | 0.290 |
Why?
|
| Analysis of Variance | 3 | 2015 | 6365 | 0.290 |
Why?
|
| Contactins | 2 | 2017 | 21 | 0.290 |
Why?
|
| Biotechnology | 1 | 2008 | 278 | 0.280 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 1707 | 0.270 |
Why?
|
| Inheritance Patterns | 6 | 2021 | 340 | 0.270 |
Why?
|
| Child | 43 | 2021 | 77478 | 0.260 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 4 | 2008 | 422 | 0.260 |
Why?
|
| Family | 7 | 2020 | 3144 | 0.250 |
Why?
|
| Conduct Disorder | 3 | 2013 | 241 | 0.240 |
Why?
|
| Trout | 1 | 2023 | 18 | 0.240 |
Why?
|
| Cadherins | 3 | 2018 | 906 | 0.240 |
Why?
|
| Tobacco Use Disorder | 3 | 2020 | 685 | 0.240 |
Why?
|
| Tic Disorders | 2 | 2019 | 127 | 0.230 |
Why?
|
| Synapses | 3 | 2019 | 1724 | 0.230 |
Why?
|
| Breeding | 1 | 2023 | 51 | 0.230 |
Why?
|
| Environment | 4 | 2017 | 1115 | 0.230 |
Why?
|
| Genetic Testing | 6 | 2021 | 3439 | 0.230 |
Why?
|
| Sweden | 5 | 2018 | 1343 | 0.220 |
Why?
|
| Hunger | 1 | 2003 | 198 | 0.210 |
Why?
|
| Regression Analysis | 7 | 2019 | 6452 | 0.210 |
Why?
|
| Clozapine | 2 | 2016 | 498 | 0.210 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2022 | 51 | 0.200 |
Why?
|
| Depressive Disorder, Major | 6 | 2020 | 4628 | 0.200 |
Why?
|
| Genetics, Medical | 3 | 2020 | 337 | 0.200 |
Why?
|
| Biostatistics | 2 | 2020 | 160 | 0.200 |
Why?
|
| Proteins | 4 | 2018 | 6096 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2021 | 11695 | 0.200 |
Why?
|
| Genetic Research | 2 | 2015 | 174 | 0.200 |
Why?
|
| Finland | 6 | 2023 | 602 | 0.200 |
Why?
|
| Hypothalamus | 2 | 2018 | 1063 | 0.200 |
Why?
|
| INDEL Mutation | 2 | 2023 | 279 | 0.200 |
Why?
|
| Selection, Genetic | 4 | 2023 | 914 | 0.190 |
Why?
|
| Genes, Recessive | 2 | 2015 | 642 | 0.190 |
Why?
|
| DNA, Mitochondrial | 2 | 2023 | 814 | 0.190 |
Why?
|
| Impulsive Behavior | 2 | 2021 | 316 | 0.190 |
Why?
|
| Gene Dosage | 5 | 2022 | 1251 | 0.190 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 304 | 0.190 |
Why?
|
| Abortion, Habitual | 1 | 2020 | 70 | 0.190 |
Why?
|
| Risk Factors | 34 | 2023 | 72145 | 0.180 |
Why?
|
| DNA Mutational Analysis | 5 | 2021 | 4187 | 0.180 |
Why?
|
| Computational Biology | 5 | 2019 | 3518 | 0.180 |
Why?
|
| Cohort Studies | 20 | 2022 | 40450 | 0.180 |
Why?
|
| Brain | 11 | 2023 | 26343 | 0.180 |
Why?
|
| Genes | 1 | 2004 | 1892 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 5 | 2023 | 527 | 0.180 |
Why?
|
| Body Height | 2 | 2019 | 1574 | 0.180 |
Why?
|
| Age of Onset | 6 | 2020 | 3266 | 0.180 |
Why?
|
| Adult | 48 | 2022 | 213712 | 0.180 |
Why?
|
| Aging | 5 | 2021 | 8626 | 0.170 |
Why?
|
| Organelles | 1 | 2021 | 265 | 0.170 |
Why?
|
| Adolescent | 29 | 2021 | 85649 | 0.170 |
Why?
|
| Preimplantation Diagnosis | 1 | 2021 | 151 | 0.170 |
Why?
|
| Genes, Essential | 1 | 2020 | 182 | 0.170 |
Why?
|
| Risk | 6 | 2020 | 9679 | 0.170 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 116 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2906 | 0.170 |
Why?
|
| Chromosomes, Human | 4 | 2021 | 457 | 0.170 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2021 | 581 | 0.170 |
Why?
|
| Comorbidity | 12 | 2022 | 10372 | 0.160 |
Why?
|
| Concept Formation | 1 | 2019 | 158 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2021 | 12164 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2019 | 1860 | 0.160 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 7721 | 0.160 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 75 | 0.160 |
Why?
|
| Receptors, Cell Surface | 2 | 2018 | 2867 | 0.160 |
Why?
|
| Biological Psychiatry | 1 | 2017 | 25 | 0.160 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 11 | 0.150 |
Why?
|
| Homosexuality, Female | 1 | 2019 | 157 | 0.150 |
Why?
|
| Valine-tRNA Ligase | 1 | 2017 | 2 | 0.150 |
Why?
|
| Migraine without Aura | 1 | 2018 | 84 | 0.150 |
Why?
|
| Colitis, Ulcerative | 3 | 2016 | 1901 | 0.150 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2018 | 271 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1086 | 0.150 |
Why?
|
| RNA Splice Sites | 1 | 2018 | 209 | 0.150 |
Why?
|
| Logistic Models | 6 | 2017 | 13403 | 0.150 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 939 | 0.150 |
Why?
|
| Child, Preschool | 15 | 2019 | 40955 | 0.140 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2017 | 117 | 0.140 |
Why?
|
| Empirical Research | 1 | 2017 | 120 | 0.140 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 171 | 0.140 |
Why?
|
| Chromatin | 3 | 2018 | 2917 | 0.140 |
Why?
|
| Reproduction | 2 | 2018 | 668 | 0.140 |
Why?
|
| Jews | 1 | 2018 | 385 | 0.140 |
Why?
|
| Rare Diseases | 2 | 2018 | 554 | 0.140 |
Why?
|
| Migraine with Aura | 1 | 2018 | 203 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 265 | 0.130 |
Why?
|
| Heredity | 1 | 2016 | 154 | 0.130 |
Why?
|
| Methylphenidate | 2 | 2010 | 473 | 0.130 |
Why?
|
| Parents | 5 | 2020 | 3387 | 0.130 |
Why?
|
| RNA Splicing | 2 | 2018 | 907 | 0.130 |
Why?
|
| Gene Deletion | 3 | 2013 | 2751 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 252 | 0.130 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 542 | 0.130 |
Why?
|
| Nucleotides | 1 | 2018 | 463 | 0.130 |
Why?
|
| Verbal Behavior | 1 | 2017 | 339 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 3381 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1692 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 1813 | 0.130 |
Why?
|
| Fasting | 3 | 2017 | 1589 | 0.130 |
Why?
|
| Menstrual Cycle | 1 | 2018 | 551 | 0.130 |
Why?
|
| Paternal Exposure | 1 | 2015 | 89 | 0.130 |
Why?
|
| Cardiovascular Diseases | 6 | 2021 | 15108 | 0.130 |
Why?
|
| Erectile Dysfunction | 1 | 2018 | 459 | 0.130 |
Why?
|
| Agranulocytosis | 1 | 2014 | 100 | 0.120 |
Why?
|
| Consanguinity | 1 | 2016 | 456 | 0.120 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2354 | 0.120 |
Why?
|
| Crohn Disease | 3 | 2018 | 2301 | 0.120 |
Why?
|
| Bayes Theorem | 3 | 2023 | 2303 | 0.120 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2018 | 369 | 0.120 |
Why?
|
| Migraine Disorders | 3 | 2018 | 1620 | 0.120 |
Why?
|
| Educational Status | 2 | 2021 | 2533 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9639 | 0.120 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 603 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2968 | 0.120 |
Why?
|
| Euphoria | 1 | 2014 | 67 | 0.120 |
Why?
|
| Lipoprotein(a) | 1 | 2018 | 425 | 0.120 |
Why?
|
| Alcoholism | 3 | 2020 | 1904 | 0.120 |
Why?
|
| Germ-Line Mutation | 3 | 2016 | 1786 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2021 | 1359 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2020 | 1533 | 0.120 |
Why?
|
| Dextroamphetamine | 1 | 2014 | 129 | 0.120 |
Why?
|
| Odds Ratio | 8 | 2019 | 9846 | 0.120 |
Why?
|
| Europe | 6 | 2021 | 3339 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 186 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2290 | 0.110 |
Why?
|
| Fibronectins | 1 | 2017 | 723 | 0.110 |
Why?
|
| Risk Assessment | 7 | 2020 | 23320 | 0.110 |
Why?
|
| Education | 1 | 2016 | 543 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 657 | 0.110 |
Why?
|
| Fertilization in Vitro | 1 | 2021 | 1284 | 0.110 |
Why?
|
| Informed Consent | 1 | 2019 | 991 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1727 | 0.110 |
Why?
|
| Smoking | 4 | 2008 | 8969 | 0.110 |
Why?
|
| HLA-B Antigens | 1 | 2014 | 353 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2020 | 774 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1118 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2018 | 380 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2015 | 288 | 0.110 |
Why?
|
| Cognition | 3 | 2023 | 6722 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2021 | 878 | 0.110 |
Why?
|
| Fibrillar Collagens | 1 | 2012 | 41 | 0.110 |
Why?
|
| Language | 2 | 2019 | 1458 | 0.110 |
Why?
|
| Cannabis | 1 | 2019 | 432 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 780 | 0.100 |
Why?
|
| Psychotic Disorders | 3 | 2023 | 3040 | 0.100 |
Why?
|
| Immunity | 1 | 2018 | 1011 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Cluster Analysis | 4 | 2012 | 2713 | 0.100 |
Why?
|
| Linear Models | 2 | 2020 | 5948 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2020 | 2739 | 0.100 |
Why?
|
| Brain Diseases | 2 | 2018 | 1554 | 0.100 |
Why?
|
| Denmark | 3 | 2019 | 736 | 0.100 |
Why?
|
| Cholesterol | 1 | 2021 | 2895 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3920 | 0.100 |
Why?
|
| Homosexuality, Male | 1 | 2019 | 1238 | 0.100 |
Why?
|
| Placenta | 1 | 2020 | 1694 | 0.100 |
Why?
|
| Founder Effect | 2 | 2009 | 190 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2417 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2017 | 1382 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2015 | 3695 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2021 | 2050 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2003 | 3187 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2010 | 1148 | 0.100 |
Why?
|
| Neutropenia | 1 | 2016 | 891 | 0.100 |
Why?
|
| Communication | 2 | 2023 | 3728 | 0.100 |
Why?
|
| Chromosome Aberrations | 2 | 2021 | 1811 | 0.100 |
Why?
|
| Complement C3b Inactivator Proteins | 1 | 2010 | 17 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1728 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2013 | 355 | 0.090 |
Why?
|
| DNA | 2 | 2023 | 7289 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3584 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2012 | 512 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2020 | 1581 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 678 | 0.090 |
Why?
|
| Middle Aged | 27 | 2021 | 213127 | 0.090 |
Why?
|
| Lod Score | 3 | 2008 | 615 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 4248 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2018 | 5867 | 0.090 |
Why?
|
| Mitochondria | 1 | 2023 | 3520 | 0.090 |
Why?
|
| Insulin | 2 | 2017 | 6575 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2012 | 537 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2017 | 7873 | 0.090 |
Why?
|
| Minisatellite Repeats | 2 | 2007 | 165 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 15056 | 0.090 |
Why?
|
| Complement Factor H | 1 | 2010 | 110 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.090 |
Why?
|
| Polymorphism, Genetic | 3 | 2018 | 4328 | 0.090 |
Why?
|
| Parturition | 2 | 2018 | 436 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2016 | 2556 | 0.090 |
Why?
|
| Heterozygote | 4 | 2023 | 2790 | 0.090 |
Why?
|
| Motor Neurons | 2 | 2019 | 851 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2117 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 761 | 0.090 |
Why?
|
| Dialysis | 1 | 2008 | 75 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2857 | 0.080 |
Why?
|
| Complement Factor I | 1 | 2008 | 14 | 0.080 |
Why?
|
| Obesity | 5 | 2014 | 12705 | 0.080 |
Why?
|
| Family Health | 2 | 2012 | 1282 | 0.080 |
Why?
|
| Fungemia | 1 | 2008 | 53 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1145 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2007 | 508 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9410 | 0.080 |
Why?
|
| Aggression | 1 | 2013 | 753 | 0.080 |
Why?
|
| Israel | 2 | 2008 | 795 | 0.080 |
Why?
|
| Fluconazole | 1 | 2008 | 146 | 0.080 |
Why?
|
| Expressed Emotion | 1 | 2008 | 92 | 0.080 |
Why?
|
| Programming Languages | 1 | 2008 | 134 | 0.080 |
Why?
|
| Veterans | 2 | 2019 | 2513 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 450 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2502 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2020 | 1945 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1350 | 0.080 |
Why?
|
| Gene Expression | 2 | 2018 | 7790 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2440 | 0.080 |
Why?
|
| Demography | 1 | 2013 | 1650 | 0.080 |
Why?
|
| Acute Coronary Syndrome | 1 | 2021 | 2337 | 0.080 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 1820 | 0.080 |
Why?
|
| Nervous System Diseases | 2 | 2015 | 1617 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2015 | 848 | 0.070 |
Why?
|
| Military Personnel | 1 | 2016 | 1132 | 0.070 |
Why?
|
| Population | 1 | 2007 | 142 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2589 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2014 | 831 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2007 | 106 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 2062 | 0.070 |
Why?
|
| Histone Acetyltransferases | 1 | 2008 | 336 | 0.070 |
Why?
|
| Body Mass Index | 5 | 2018 | 12695 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2020 | 4250 | 0.070 |
Why?
|
| Chemoprevention | 1 | 2008 | 319 | 0.070 |
Why?
|
| Neoplasms | 3 | 2020 | 21596 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2042 | 0.070 |
Why?
|
| Aged | 18 | 2023 | 162944 | 0.070 |
Why?
|
| Candidiasis | 1 | 2008 | 365 | 0.070 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2008 | 322 | 0.070 |
Why?
|
| Proteomics | 1 | 2019 | 3618 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2007 | 327 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1452 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 657 | 0.070 |
Why?
|
| Waist-Hip Ratio | 2 | 2020 | 517 | 0.070 |
Why?
|
| Triglycerides | 1 | 2013 | 2450 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2008 | 435 | 0.070 |
Why?
|
| Young Adult | 11 | 2021 | 56350 | 0.070 |
Why?
|
| Complement C3 | 1 | 2007 | 460 | 0.070 |
Why?
|
| Drive | 1 | 2005 | 35 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2010 | 1122 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2018 | 351 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2066 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2006 | 374 | 0.060 |
Why?
|
| Quality Control | 2 | 2022 | 841 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2019 | 6030 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 3510 | 0.060 |
Why?
|
| Personality | 2 | 2008 | 548 | 0.060 |
Why?
|
| Animals | 10 | 2023 | 168561 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2940 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 596 | 0.060 |
Why?
|
| Registries | 3 | 2018 | 8077 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2008 | 729 | 0.060 |
Why?
|
| Chromosomes, Human, X | 2 | 2016 | 296 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3861 | 0.060 |
Why?
|
| Cognition Disorders | 2 | 2014 | 4030 | 0.060 |
Why?
|
| Probability | 4 | 2008 | 2502 | 0.060 |
Why?
|
| Genetic Structures | 1 | 2022 | 12 | 0.060 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 7988 | 0.060 |
Why?
|
| Africa, Southern | 1 | 2022 | 57 | 0.050 |
Why?
|
| Social Environment | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1503 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2004 | 462 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| Organ Size | 2 | 2019 | 2253 | 0.050 |
Why?
|
| Paternity | 1 | 2001 | 16 | 0.050 |
Why?
|
| Internationality | 1 | 2008 | 1002 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2005 | 1026 | 0.050 |
Why?
|
| Seasons | 1 | 2008 | 1492 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2007 | 2372 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2004 | 365 | 0.050 |
Why?
|
| Thinness | 1 | 2005 | 479 | 0.050 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 13921 | 0.050 |
Why?
|
| G-Quadruplexes | 1 | 2023 | 162 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 3058 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3076 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 15194 | 0.050 |
Why?
|
| Nuclear Family | 1 | 2001 | 318 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2092 | 0.050 |
Why?
|
| Access to Information | 1 | 2023 | 320 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2019 | 15530 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 329 | 0.050 |
Why?
|
| Zebrafish | 3 | 2019 | 2990 | 0.050 |
Why?
|
| Body Image | 1 | 2005 | 609 | 0.050 |
Why?
|
| Social Responsibility | 1 | 2023 | 389 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12242 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2017 | 8541 | 0.040 |
Why?
|
| Schools | 1 | 2008 | 1425 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2019 | 43 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2130 | 0.040 |
Why?
|
| Synaptosomes | 1 | 2019 | 115 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 480 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 85 | 0.040 |
Why?
|
| Norway | 1 | 2020 | 446 | 0.040 |
Why?
|
| Cell Line | 3 | 2022 | 15994 | 0.040 |
Why?
|
| Africa | 1 | 2021 | 670 | 0.040 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2684 | 0.040 |
Why?
|
| Paternal Age | 1 | 2019 | 84 | 0.040 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2011 | 212 | 0.040 |
Why?
|
| Diploidy | 1 | 2018 | 138 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2020 | 3020 | 0.040 |
Why?
|
| Sex Factors | 3 | 2020 | 10392 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 440 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2005 | 1106 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2019 | 152 | 0.040 |
Why?
|
| Smoking Cessation | 2 | 2008 | 2068 | 0.040 |
Why?
|
| Gene Flow | 1 | 2018 | 79 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2021 | 935 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2017 | 23387 | 0.040 |
Why?
|
| Putamen | 1 | 2019 | 291 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 573 | 0.040 |
Why?
|
| Population Density | 1 | 2018 | 194 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2885 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 393 | 0.040 |
Why?
|
| Motivation | 1 | 2007 | 1968 | 0.040 |
Why?
|
| Americas | 1 | 2017 | 111 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2011 | 6249 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2017 | 126 | 0.040 |
Why?
|
| Neurons | 3 | 2022 | 9325 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 783 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 2410 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 895 | 0.040 |
Why?
|
| Human Genome Project | 1 | 2017 | 192 | 0.040 |
Why?
|
| Mississippi | 1 | 2016 | 89 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2018 | 480 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 315 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1792 | 0.030 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 366 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2017 | 121 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 2018 | 229 | 0.030 |
Why?
|
| Parkinsonian Disorders | 1 | 2019 | 272 | 0.030 |
Why?
|
| Taiwan | 1 | 2017 | 496 | 0.030 |
Why?
|
| Frontal Lobe | 2 | 2013 | 1407 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2018 | 179 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 468 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3639 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 230 | 0.030 |
Why?
|
| Communication Disorders | 1 | 2016 | 51 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2020 | 637 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 57683 | 0.030 |
Why?
|
| Hydatidiform Mole | 1 | 2018 | 279 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 669 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 1953 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 2018 | 262 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 504 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 991 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3731 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 491 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1202 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 644 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2016 | 366 | 0.030 |
Why?
|
| Munchausen Syndrome by Proxy | 1 | 1994 | 18 | 0.030 |
Why?
|
| China | 1 | 2021 | 2246 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 403 | 0.030 |
Why?
|
| Age Factors | 3 | 2017 | 18355 | 0.030 |
Why?
|
| Health | 1 | 2018 | 390 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19862 | 0.030 |
Why?
|
| Models, Psychological | 3 | 2007 | 810 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 703 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2018 | 1154 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 154 | 0.030 |
Why?
|
| Ovary | 1 | 2018 | 981 | 0.030 |
Why?
|
| Adipokines | 1 | 2016 | 318 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2016 | 250 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 867 | 0.030 |
Why?
|
| Philadelphia | 1 | 2014 | 263 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2335 | 0.030 |
Why?
|
| Intelligence | 1 | 2019 | 920 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6454 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2014 | 165 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 281 | 0.030 |
Why?
|
| Population Control | 1 | 2013 | 20 | 0.030 |
Why?
|
| Weight Loss | 1 | 2005 | 2604 | 0.030 |
Why?
|
| Amidine-Lyases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2935 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 505 | 0.030 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2012 | 34 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2020 | 13029 | 0.030 |
Why?
|
| Protective Agents | 1 | 2014 | 156 | 0.030 |
Why?
|
| Prognosis | 3 | 2020 | 29010 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 6974 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2016 | 5019 | 0.030 |
Why?
|
| Proinsulin | 1 | 2012 | 133 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 1438 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1107 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1185 | 0.030 |
Why?
|
| Leukocytes | 1 | 2020 | 2039 | 0.030 |
Why?
|
| Artifacts | 1 | 2021 | 1903 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 20774 | 0.030 |
Why?
|
| Personality Assessment | 2 | 2010 | 643 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2013 | 330 | 0.030 |
Why?
|
| Testis | 1 | 2015 | 800 | 0.030 |
Why?
|
| Self Report | 1 | 2023 | 3548 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 933 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2747 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 2003 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2012 | 173 | 0.030 |
Why?
|
| Benchmarking | 1 | 2018 | 1038 | 0.030 |
Why?
|
| Phylogeny | 1 | 2019 | 2797 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2020 | 2504 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 272 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2015 | 625 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2011 | 87 | 0.020 |
Why?
|
| Behavior | 1 | 2014 | 560 | 0.020 |
Why?
|
| Amygdala | 1 | 2019 | 1305 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1692 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2018 | 1677 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 9735 | 0.020 |
Why?
|
| Mental Health | 1 | 2005 | 2997 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 1008 | 0.020 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2010 | 91 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12344 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8455 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Depression | 3 | 2018 | 7733 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2016 | 968 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2011 | 245 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 628 | 0.020 |
Why?
|
| Pregnancy | 3 | 2020 | 29087 | 0.020 |
Why?
|
| Social Behavior | 1 | 2017 | 1128 | 0.020 |
Why?
|
| Albuminuria | 1 | 2014 | 683 | 0.020 |
Why?
|
| Binding Sites | 1 | 2018 | 6115 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2170 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 1286 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2009 | 50 | 0.020 |
Why?
|
| Point Mutation | 1 | 2015 | 1624 | 0.020 |
Why?
|
| Germany | 1 | 2011 | 860 | 0.020 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2008 | 27 | 0.020 |
Why?
|
| Neuregulins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18006 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 1 | 2008 | 32 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2018 | 1513 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2119 | 0.020 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2008 | 66 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 553 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 711 | 0.020 |
Why?
|
| Executive Function | 1 | 2017 | 1362 | 0.020 |
Why?
|
| Mass Screening | 1 | 2004 | 5238 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 4553 | 0.020 |
Why?
|
| Social Class | 1 | 2017 | 1995 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1155 | 0.020 |
Why?
|
| Antisocial Personality Disorder | 1 | 2008 | 227 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Menopause | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40054 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 374 | 0.020 |
Why?
|
| Interview, Psychological | 2 | 2005 | 812 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1400 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.020 |
Why?
|
| Bone Density | 1 | 2020 | 3469 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1363 | 0.020 |
Why?
|
| Diagnosis | 1 | 2007 | 154 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 983 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2006 | 52 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2010 | 582 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4554 | 0.020 |
Why?
|
| Hippocampus | 1 | 2019 | 3661 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2006 | 89 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2006 | 178 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1490 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 1458 | 0.020 |
Why?
|
| Dyslexia | 1 | 2008 | 248 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1421 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3444 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3574 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2009 | 850 | 0.020 |
Why?
|
| Dysthymic Disorder | 1 | 2005 | 74 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 2597 | 0.020 |
Why?
|
| Agoraphobia | 1 | 2005 | 179 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2007 | 312 | 0.020 |
Why?
|
| Bupropion | 1 | 2007 | 303 | 0.020 |
Why?
|
| Virginia | 1 | 2004 | 121 | 0.020 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 271 | 0.020 |
Why?
|
| Ireland | 1 | 2004 | 160 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 747 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2004 | 236 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7716 | 0.010 |
Why?
|
| Mothers | 1 | 1994 | 2163 | 0.010 |
Why?
|
| Child Behavior Disorders | 1 | 2008 | 807 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1661 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2004 | 142 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3151 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 497 | 0.010 |
Why?
|
| Achievement | 1 | 2004 | 291 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2004 | 458 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 2005 | 439 | 0.010 |
Why?
|
| Anxiety | 1 | 2017 | 4279 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13814 | 0.010 |
Why?
|
| Nerve Net | 1 | 2014 | 2174 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2842 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2915 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 749 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2970 | 0.010 |
Why?
|
| Seizures | 1 | 2014 | 2851 | 0.010 |
Why?
|
| Nicotine | 1 | 2007 | 677 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16665 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2536 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2593 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 800 | 0.010 |
Why?
|
| Panic Disorder | 1 | 2005 | 616 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18112 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 288 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2536 | 0.010 |
Why?
|
| Drosophila | 1 | 2008 | 1484 | 0.010 |
Why?
|
| Telephone | 1 | 2004 | 617 | 0.010 |
Why?
|
| Research Design | 2 | 2010 | 5979 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2013 | 3748 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3462 | 0.010 |
Why?
|
| Arousal | 1 | 2005 | 1165 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14720 | 0.010 |
Why?
|
| Eating | 1 | 2005 | 1535 | 0.010 |
Why?
|
| Affect | 1 | 2005 | 1473 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11039 | 0.010 |
Why?
|
| Forecasting | 1 | 2005 | 2948 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39004 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2008 | 3679 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2008 | 3203 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13256 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 24913 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 35070 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2008 | 62966 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 20928 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 81045 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2008 | 77098 | 0.000 |
Why?
|
| United States | 1 | 2008 | 69693 | 0.000 |
Why?
|